Pharmaids Pharmaceuticals Ltd Financials
Company Logo

Pharmaids Pharmaceuticals Ltd Financial Statement

Pharmaids Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue1.46
Operating Expense5.99
Net Profit-4.36
Net Profit Margin-298.63
Earning Per Share-1.24
EBIDTA-3.20
Effective Tax RateTBA

Pharmaids Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual2.34
Operating Expenses Annual9.60
Operating Profit Annual-6.24
Interest Annual2.15
Depreciation0.20
Net Profit Annual-7.28
Tax Annual-1.31

Pharmaids Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning2.46
Cash Flow from Operations-7.72
Cash Flow from Investing-18.90
Cash Flow from Financing24.64
Cash Flow at the End0.47

Pharmaids Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)-266.67
PBIT Margin (%)-275.21
PBT Margin (%)-147.00
Net PROFIT Margin (%)-311.11
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-6.22
Total Debt / Equity (X)0.39
Asset Turnover Ratio (%)0.02

Pharmaids Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual24.18
Total Current Assets Annual12.68
Non Current Assets Annual106.01
Total Shareholders Funds Annual63.79
Total Assets Annual118.69

Pharmaids Pharmaceuticals Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-1.41

Surprise

0.00%

Mar 2025

EPS beaten by 0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

FAQS on Pharmaids Pharmaceuticals Ltd Financials

As of Sep 11, 2025, Pharmaids Pharmaceuticals Ltd has a market capitalization of 242.18 Cr. Value Research classifies it as a Small-Cap company.

Yes, Pharmaids Pharmaceuticals Ltd is not with a debt-to-equity ratio of 0.62.

In FY 2024 , Pharmaids Pharmaceuticals Ltd recorded a total revenue of approximately 2.34 Cr marking a significant milestone in the company's financial performance.

Pharmaids Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.8% and Infinity% annually, respectively..

Pharmaids Pharmaceuticals Ltd's current PE ratio is -33.27.

Pharmaids Pharmaceuticals Ltd's ROCE averaged -19.1% from the FY ending March 2023 to 2025, with a median of -6.9%. It peaked at -6.2% in March 2025, reflecting strong capital efficiency over the period..

Pharmaids Pharmaceuticals Ltd's latest EBIT is Rs. -6.44 Cr, surpassing the average EBIT of Rs. -7.37 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions